Centrifugal Blood Pumps Market – By Product Type (Electrical, Mechanical), Application (Short-Term Support, Long-Term Support), End-use (Hospitals, Ambulatory Surgical Centers, Specialty Clinics) - Global Forecast (2024 – 2032)

Centrifugal Blood Pumps Market Size

Centrifugal Blood Pumps Market size was valued at around USD 95.1 million in 2023 and is estimated to grow at 5.3% CAGR from 2024 to 2032. Centrifugal blood pumps are mechanical devices used to assist or replace the heart's function in pumping blood throughout the body. They operate on the principle of centrifugal force, where blood is drawn into the pump and accelerated outward by a rotating impeller or rotor. This acceleration creates a pressure gradient that propels the blood into the circulatory system.
 

The rising prevalence of cardiovascular diseases (CVDs) is a significant catalyst for the market. With an aging population and lifestyle factors such as obesity, hypertension, and diabetes on the rise, the incidence of conditions like heart failure and coronary artery disease is also increasing. For instance, according to a 2023 study from the National Library of Medicine, around 6.7 million adults in the U.S. have heart failure (HF), a figure expected to grow to 8.5 million by 2030. The lifetime risk of developing HF has reached 24%, indicating that roughly one in four people will experience heart failure at some stage in their lives. Centrifugal blood pumps play a crucial role in managing severe cases of heart failure and complex cardiac procedures, thereby enhancing patient outcomes. This growing need for effective cardiac support solutions is driving market growth.
 

Moreover, increasing investment in cardiovascular research and development (R&D) is a major accelerator for the centrifugal blood pumps market. Funding from both public and private sectors fosters the advancement of innovative technologies and therapies for cardiovascular diseases. Research focuses on enhancing pump designs, materials, and integration with other cardiac systems, leading to more effective and safer devices. Collaborative efforts accelerate the translation of research into clinical practice, boosting the development of next-generation centrifugal blood pumps and driving market innovation and growth.
 

Centrifugal Blood Pumps Market Trends

• Technological advancements in centrifugal blood pumps have significantly influenced the market's growth.
   
• Innovations such as magnetic levitation technology, which reduces mechanical wear and enhances pump reliability, have revolutionized the field. Additionally, advanced monitoring and control systems have been integrated to provide real-time data on pump performance and patient conditions, improving safety and efficacy.
   
• These technological advancements not only enhance the performance and reliability of centrifugal blood pumps but also broaden their use in both acute and chronic cardiovascular care, fueling market expansion.
   

Centrifugal Blood Pumps Market Analysis

Based on product type, the market is divided into electrical and mechanical. The electrical segment of the market is forecasted to reach USD 113.8 million by 2032.
 

• Electrical centrifugal blood pumps offer advanced features, including precision control and enhanced performance, which are increasingly valued in modern medical settings. These pumps are designed with advanced technology that enables real-time adjustments and improved efficiency in managing blood flow during complex surgical procedures or in critical care settings.
   
• Additionally, ongoing advancements in electronics and miniaturization are contributing to the development of more sophisticated and reliable electrical pumps, further driving their adoption.

Based on application, the centrifugal blood pumps market is bifurcated into short-term support and long-term support. The long-term support segment accounted for USD 37.1 million in 2023, driven by the growing demand for durable solutions to manage chronic cardiovascular conditions.
 

• The strong performance of this segment can be attributed to the increasing use of centrifugal pumps in advanced therapies such as extracorporeal membrane oxygenation (ECMO) and ventricular assist devices (VADs).
   
• ECMO systems, which provide critical cardiac and respiratory support, often require long-term pump solutions to ensure continuous and reliable operation. Similarly, VADs, which assist patients with severe heart failure by helping the heart pump blood more effectively, benefit from the high efficiency and endurance of centrifugal pumps designed for extended use.
   
• Technological advancements have enhanced the reliability and patient comfort of these long-term support systems, making them essential tools in managing complex cardiovascular conditions and contributing to the segment's significant market share.
   

Based on end-use, the centrifugal blood pumps market is bifurcated into hospitals, ambulatory surgical centers, specialty clinics, and other end-users. The hospitals segment accounted for USD 42.6 million in 2023.
 

• Hospitals, as primary centers for critical care, require reliable and high-performance centrifugal blood pumps for complex procedures, such as heart surgeries and emergency interventions.
   
• The segment's substantial market share is driven by hospitals' extensive use of these pumps to manage patients with severe heart conditions, where precision and efficiency are crucial.
   
• Additionally, hospitals are continually upgrading their medical equipment to ensure optimal patient outcomes and to comply with evolving healthcare standards, which stimulates the demand for cutting-edge centrifugal blood pumps.
   
• Significant investments in healthcare infrastructure and the growing prevalence of cardiovascular diseases further strengthen the dominance of this segment in the market

The growth of the centrifugal blood pumps market in the U.S., projected to reach USD 58.4 million by 2032.
 

• The prevalence of cardiovascular diseases (CVDs), such as heart failure and coronary artery disease, is rising in the U.S. This increasing incidence drives the demand for advanced medical devices, including centrifugal blood pumps, which are essential for managing severe cardiac conditions and supporting patients undergoing heart surgery.
   

The centrifugal blood pumps market in UK is expected to experience significant and promising growth from 2024 to 2032.
 

• Hospitals and specialized cardiac centers are increasingly adopting centrifugal blood pumps for their efficacy in providing circulatory support during complex cardiac procedures. As the healthcare infrastructure in the UK continues to expand and modernize, the demand for high-quality, reliable blood pumps will grow.
   

Japan centrifugal blood pumps market is anticipated to witness lucrative growth between 2024 – 2032.
 

• Continuous innovations in centrifugal blood pump technology, including advancements in pump design, material science, and automation, are enhancing the efficiency and safety of these devices.
   
• For instance, developments in magnetically levitated pumps and miniaturized designs contribute to improved performance and patient outcomes. These advancements increase the appeal of centrifugal blood pumps to healthcare providers, thereby stimulating market growth in the country.
   

The centrifugal blood pumps market in Saudi Arabia is expected to experience significant and promising growth from 2024 to 2032.
 

• The Saudi Arabian government and private sector are increasing their investment in healthcare. This rise in expenditure facilitates the acquisition of advanced medical equipment, including centrifugal blood pumps. Increased funding supports the procurement of high-quality devices and the expansion of healthcare services.
   

Centrifugal Blood Pumps Market Share

The market is highly competitive, featuring a mix of major global companies and smaller to mid-sized firms. Leading players prioritize innovation, investing heavily in research and development to improve product performance and meet evolving regulatory requirements. Additionally, strategic partnerships, acquisitions, and mergers are crucial in reinforcing market positions and expanding global reach.
 

Centrifugal Blood Pumps Market Companies

Some of the eminent market participants operating in the centrifugal blood pumps industry include:

• Abbott Laboratories
• Braile Biomedica
• Getinge AB
• Hugo Sachs Elektronik
• LivaNova PLC
• Medtronic plc
• Senko Medical Instrument Mfg. Co., Ltd.
• Spectrum Medical
• Terumo Corporation
   

Centrifugal Blood Pumps Industry News:

• In April 2023, Abbott received FDA clearance for its CentriMag Blood Pump, approved for longer-term use in adults needing extracorporeal membrane oxygenation (ECMO) for critical heart and lung conditions. This approval provided physicians with more time for treatment decisions and gave company a competitive edge in the market.
   

The centrifugal blood pumps market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

• Electrical
• Mechanical

Market, By Application

• Short-term support
• Long-term support

Market, By End-use

• Hospitals
• Ambulatory surgical centers
• Specialty clinics
• Other end-users

The above information is provided for the following regions and countries:

• North America 
  • U.S.
  • Canada 
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
  • Rest of Europe 
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific 
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America 
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa